What Do Hospitalists Need to Know About Monkeypox?
June 24, 2022
What is monkeypox? Monkeypox is a rare infection caused by the monkeypox virus. Monkeypox virus belongs to the Orthopoxvirus genus in the family Poxviridae. The Orthopoxvirus genus also includes...
#HowWeHospitalist: A glimpse into six lives
February 16, 2022
They’ve been called heroes and godsends and walked out of work to applause from passersby. That respect and admiration was a balm to overworked hospitalists. Now many of the nation’s estimated...
Outpatient COVID-19 therapeutics reduce hospitalization and mortality
February 10, 2022
Matching the right patient to the right therapeutic at the right time In late 2021 and early 2022, the Food and Drug Administration (FDA) granted emergency use authorizations (EUAs) for the...
Rollout of COVID-19 monoclonal antibodies lacked unified plan: expert panel
February 8, 2021
Monoclonal antibodies are in ample supply, but a lack of a plan to administer them has led to major underutilization of these therapies.
J&J vaccine 85% efficacious against severe COVID globally
February 1, 2021
The efficacy against severe disease provided by the Janssen/J&J vaccine held true regardless of age, race/ethnicity, absence or presence of comorbidities, and geography.
What we know and don’t know about virus variants and vaccines
January 22, 2021
One of the major concerns remains the ability of COVID-19 vaccines to work on new strains.
Long-haul COVID-19 cases rise as stigma of chronic fatigue taunts
January 15, 2021
An estimated three-quarters of all patients with chronic fatigue syndrome report that their symptoms started after a viral infection.
U.S. hits 20 million cases as COVID variant spreads
January 4, 2021
It took 292 days for the US to reach its first 10 million cases, and just 54 more days to double that number.
Understanding messenger RNA and other SARS-CoV-2 vaccines
December 14, 2020
Technological advances make these new and revolutionary vaccines a reality.
Prioritize COVID-19 vaccination in both types of diabetes, say docs
December 9, 2020
The study is the first to prospectively evaluate COVID-19 severity factors and death in people with type 1 and type 2 diabetes separately.